BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780)
2,800.00
-10.00 (-0.36%)
Nov 4, 2026, 3:15 PM KST
BCWORLD PHARM. Revenue
BCWORLD PHARM. had revenue of 20.96B KRW in the quarter ending June 30, 2026, with 2.52% growth. This brings the company's total for the last twelve months to 80.33B, up 6.65% year-over-year. In the year 2025, BCWORLD PHARM. had annual revenue of 75.80B with 1.32% growth. That makes BCWORLD PHARM. the 26,620th largest company in the world by revenue and 1,590th in South Korea.
Revenue (ttm)
80.33B
Revenue Growth
+6.65%
P/S Ratio
0.36
Revenue / Employee
277.95M
Employees
289
Market Cap
28.62B
Revenue by Geography
- South Korea 81.93B 93.3%
- Overseas 5.90B 6.7%
Fiscal year ended Dec 31, 2025 See the full BCWORLD PHARM. breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 75.80B | 985.64M | 1.32% |
| Dec 31, 2024 | 74.81B | -296.36M | -0.39% |
| Dec 31, 2023 | 75.11B | 2.41B | 3.31% |
| Dec 31, 2022 | 72.70B | 10.62B | 17.11% |
| Dec 31, 2021 | 62.08B | 5.05B | 8.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.12T |
| Celltrion | 4.90T |
| Samsung Epis Holdings | 1.51T |
| ALTEOGEN | 254.01B |
| LabGenomics | 77.64B |
| ORIENT BIO | 59.09B |
| Tdspharm | 32.90B |
| HASS Corp. | 16.08B |